Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Visirna Therapeutics Hk Limited

Clinical trials sponsored by Visirna Therapeutics Hk Limited, explained in plain language.

Not yet finished but already full! 1 Completed 2

New drug injection targets genetic root of fatty liver disease

Disease control Ongoing

This study is testing an investigational injection called VSA006 in Chinese adults with nonalcoholic steatohepatitis (NASH), a serious form of fatty liver disease. The drug works by targeting a specific protein in the liver linked to disease progression. Researchers will measure …

Phase: PHASE2 • Sponsor: Visirna Therapeutics HK Limited • Aim: Disease control

Last updated Apr 04, 2026 08:36 UTC